Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 12Phase 1/2 5Phase EARLY_PHASE1 1Phase 3 1Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 6Genitourinary 3Sarcoma 1Head & Neck 1CNS 1

Conditions

Sarcoma 1

Interventions

Magnetic Resonance Spectroscopy 6pembrolizumab 3Specimen Handling 3Radiotherapy 3Oncolytic Virotherapy 3Nivolumab 3Irinotecan 3Cyclophosphamide 3X-Rays 2Temozolomide 2Etoposide 2Doxorubicin 2Biopsy 2Bevacizumab 2trastuzumab biosimilar HLX02 1sodium thiosulfate 1romiplostim 1pertuzumab 1perflutren 1palbociclib 1olaparib 1niraparib 1montelukast 1glucarpidase 1gamma-Glutamyl Hydrolase 1fluorodopa F 18 1eribulin 1entrectinib 1entacapone 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Ipilimumab × Sarcoma × Clear all
NCT03463408 2025-08-11

Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma

University of Rochester

Phase EARLY_PHASE1 Active not recruiting
14 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡